Shares News
Intel stock forecast: What’s next for INTC after poor earnings?
Discover the Intel (INTC) share price forecast for 2025 and beyond, with analyst price targets and more
16 hours ago
Druckenmiller just sold all his Palantir shares
f you had invested $10,000 in Palantir just three years ago, that investment would be worth over $150,000 today. That's a staggering 1,500% return. That same $10,000 invested in Nvidia, the largest company in the world, would have turned into $81,000.
15:45, 5 September 2025
Tesla stock forecast: Third-party TSLA price target
Discover the Tesla (TSLA) share price forecast for 2025 and beyond, with third-party analysts’ price targets and more.
14:41, 5 September 2025
Bill Ackman's biggest trade ever
If you invested $10,000 in Uber exactly three years ago, it would be worth over $30,000 today. That’s more than a 300% return and nearly five times the S&P 500’s performance over the same period.
13:43, 5 September 2025
US 500 index forecast: Third-party US 500 price target
Discover the US 500 (US 500) index price forecast for 2025 and beyond, with analyst price targets and more.
12:59, 5 September 2025
MicroStrategy stock forecast: Third-party MSTR price target
Discover the MicroStrategy (MSTR) share price forecast for 2025 and beyond, with analyst price targets and more.
09:48, 5 September 2025
MongoDB stock forecast 2025-2050: Third-party MDB price target
Discover the MongoDB (MDB) share price forecast for 2025 and beyond, with analyst price targets and more
08:48, 5 September 2025
US Wall Street 30 index forecast: Is US30 a Good Investment?
Discover the US Wall Street 30 (Dow Jones Industrial Average) index price forecast for 2025 and beyond, with analyst price targets and more
13:08, 3 September 2025
Coinbase stock forecast: Third-party COIN price target
Discover the Coinbase (COIN) share price outlook for 2025 and beyond, with analyst targets and more.
10:50, 3 September 2025
GlaxoSmithKline stock forecast 2025-2050: Third-party GSK price target
GlaxoSmithKline (GSK) is a leading British multinational pharmaceutical and biotechnology company, focused on vaccines, and specialty medicines.
15:30, 28 August 2025